First-Line Treatment for Patients With CML in Chronic Phase: Why Imatinib Is an Appropriate Choice

I am very comfortable in using imatinib as initial therapy in most patients who present in chronic phase, with the possible exception of patients with more advanced disease and higher Sokal scores.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news